Filovirus Entry

  • Graham Simmons
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 790)


A number of advances in recent years have significantly furthered our understanding of filovirus attachment and cellular tropism. For example, several cell-surface molecules have been identified as attachment factors with the potential to facilitate the in vivo targeting of particular cell types such as macrophages and hepatic cells. Furthermore, our knowledge of internalization and subsequent events during filovirus entry has also been widened, adding new variations to the paradigms for viral entry established for HIV and influenza. In particular, host cell factors such as endosomal proteases and the intracellular receptor Niemann-Pick C1 are now known to play a vital role in activating the membrane fusion potential of filovirus glycoproteins.


Membrane Fusion Marburg Virus Severe Acute Respiratory Syndrome Coronavirus Viral Fusion Protein Folate Receptor Alpha 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Leroy EM, Gonzalez J-P, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect 2011; 17:964–976.PubMedCrossRefGoogle Scholar
  2. 2.
    Leroy EM, Kumulungui B, Pourrut X et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438:575–576.PubMedCrossRefGoogle Scholar
  3. 3.
    Towner JS, Amman BR, Sealy TK et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009; 5:e1000536.PubMedCrossRefGoogle Scholar
  4. 4.
    Barrette RW, Metwally SA, Rowland JM et al. Discovery of swine as a host for the reston Ebola virus. Science 2009; 325:204–206.PubMedCrossRefGoogle Scholar
  5. 5.
    Volchkov VE, Becker S, Volchkova VA et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995; 214:421–430.PubMedCrossRefGoogle Scholar
  6. 6.
    Sanchez A, Ksiazek TG, Rollin PE et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 1999; 179(Suppl 1):S164–169.PubMedCrossRefGoogle Scholar
  7. 7.
    Volchkov VE, Volchkova VA, Muhlberger E et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001; 291:1965–1969.PubMedCrossRefGoogle Scholar
  8. 8.
    Yang ZY, Duckers HJ, Sullivan NJ et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6:886–889.PubMedCrossRefGoogle Scholar
  9. 9.
    Simmons G, Wool-Lewis RJ, Baribaud F et al. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Viro 2002; 76:2518–2528.CrossRefGoogle Scholar
  10. 10.
    Marzi A, Wegele A, Pohlmann S. Modulation of virion incorporation of Ebolavirus glycoprotein: Effects on attachment, cellular entry and neutralization. Virology 2006; 352:345–56.PubMedCrossRefGoogle Scholar
  11. 11.
    Volchkov VE, Feldmann H, Volchkova VA et al. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci USA 1998; 95:5762–5767.PubMedCrossRefGoogle Scholar
  12. 12.
    Volchkov VE, Volchkova VA, Stroher U et al. Proteolytic processing of Marburg virus glycoprotein. Virology 2000; 268:1–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Jeffers SA, Sanders DA, Sanchez A. Covalent modifications of the ebola virus glycoprotein. J Virol 2002; 76:12463–12472.PubMedCrossRefGoogle Scholar
  14. 14.
    Klenk HD, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol 1994;2:39–43.PubMedCrossRefGoogle Scholar
  15. 15.
    Wool-Lewis RJ, Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol 1999; 73:1419–1426.PubMedGoogle Scholar
  16. 16.
    Neumann G, Geisbert TW, Ebihara H et al. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol 2007; 81:2995–2998.PubMedCrossRefGoogle Scholar
  17. 17.
    Weissenhorn W, Carfi A, Lee KH et al. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 1998; 2:605–616.PubMedCrossRefGoogle Scholar
  18. 18.
    White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins. Crit Rev Biochem Mol Biol 2008; 43(3):189–219.PubMedCrossRefGoogle Scholar
  19. 19.
    Geyer H, Will C, Feldmann H et al. Carbohydrate structure of Marburg virus glycoprotein. Glycobiology 1992; 2:299–312.PubMedCrossRefGoogle Scholar
  20. 20.
    Lee JE, Fusco ML, Hessell AJ et al. Structure of the ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008; 454:177–182.PubMedCrossRefGoogle Scholar
  21. 21.
    Sinn PL, Hickey MA, Staber PD et al. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 2003; 77:5902–5910.PubMedCrossRefGoogle Scholar
  22. 22.
    Manicassamy B, Wang J, Jiang H et al. Comprehensive analysis of ebola virus GP1 in viral entry. J Virol 2005; 79:4793–4805.PubMedCrossRefGoogle Scholar
  23. 23.
    Kuhn JH, Radoshitzky SR, Guth AC et al. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 2006; 281:15951–15958.PubMedCrossRefGoogle Scholar
  24. 24.
    Mpanju OM, Towner JS, Dover JE et al. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res 2006; 121:205–14.PubMedCrossRefGoogle Scholar
  25. 25.
    Takada A, Robison C, Goto H et al. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 1997; 94:14764–14769.PubMedCrossRefGoogle Scholar
  26. 26.
    Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by usingpseudotyped viruses: identification of receptor-deficient cell lines. J Virol 1998; 72:3155–3160.PubMedGoogle Scholar
  27. 27.
    Chan SY, Speck RF, Ma MC et al. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 2000; 74:4933–4937.PubMedCrossRefGoogle Scholar
  28. 28.
    Ito H, Watanabe S, Takada A et al. Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies. J Virol 2001; 75:1576–1580.PubMedCrossRefGoogle Scholar
  29. 29.
    Geisbert TW, Hensley LE, Gibb TR et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171–186.PubMedCrossRefGoogle Scholar
  30. 30.
    Schnittler HJ, Feldmann H. Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. Curr Top Microbiol Immunol 1999; 235:175–204.PubMedCrossRefGoogle Scholar
  31. 31.
    Schnittler HJ, Feldmann H. Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin Infect Dis 1998; 27:404–406.PubMedCrossRefGoogle Scholar
  32. 32.
    Stroher U, West E, Bugany H et al. Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 2001; 75:11025–11033.PubMedCrossRefGoogle Scholar
  33. 33.
    Yonezawa A, Cavrois M, Greene WC. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 2005; 79:918–926.PubMedCrossRefGoogle Scholar
  34. 34.
    Bosio CM, Aman MJ, Grogan C et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 2003;188:1630–1638.PubMedCrossRefGoogle Scholar
  35. 35.
    Kondratowicz AS, Lennemann NJ, Sinn PL et al. T-cell immunoglobulin and mucin domain 1 (tim-1) is a receptor for zaire ebolavirus and lake victoria marburgvirus. Proc Natl Acad Sci USA 2011; 108:8426–8431.PubMedCrossRefGoogle Scholar
  36. 36.
    Shimojima M, Takada A, Ebihara H et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006; 80:10109–10116.PubMedCrossRefGoogle Scholar
  37. 37.
    Brindley MA, Hunt CL, Kondratowicz AS et al. Tyrosine kinase receptor axl enhances entry of zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 2011; 415:83–94.PubMedCrossRefGoogle Scholar
  38. 38.
    Chan SY, Empig CJ, Weite FJ et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 2001; 106:117–126.PubMedCrossRefGoogle Scholar
  39. 39.
    Simmons G, Rennekamp AJ, Chai N et al. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 2003; 77:13433–13438.PubMedCrossRefGoogle Scholar
  40. 40.
    Takada A, Watanabe S, Ito H et al. Downregulation of betal integrins by Ebola virus glycoprotein: implication for virus entry. Virology 2000; 278:20–26.PubMedCrossRefGoogle Scholar
  41. 41.
    O’Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000; 74:10074–10080.CrossRefGoogle Scholar
  42. 42.
    Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 2000; 165:2937–2942.PubMedGoogle Scholar
  43. 43.
    Liu W, Tang L, Zhang G et al. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem 2004; 279:18748–18758.PubMedCrossRefGoogle Scholar
  44. 44.
    Geijtenbeek TB, Krooshoop DJ, Bleijs DA et al. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 2000; 1:353–357.PubMedCrossRefGoogle Scholar
  45. 45.
    Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100:575–585.PubMedCrossRefGoogle Scholar
  46. 46.
    Curtis BM, Scharnowske S, Watson AJ. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 1992; 89:8356–8360.PubMedCrossRefGoogle Scholar
  47. 47.
    Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587–597.PubMedCrossRefGoogle Scholar
  48. 48.
    Pohlmann S, Zhang J, Baribaud F et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003; 77:4070–4080.PubMedCrossRefGoogle Scholar
  49. 49.
    Tassaneetrithep B, Burgess TH, Granelli-Piperno A et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197:823–829.PubMedCrossRefGoogle Scholar
  50. 50.
    Colmenares M, Puig-Kroger A, Pello OM et al. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J Biol Chem 2002; 277:36766–36769.PubMedCrossRefGoogle Scholar
  51. 51.
    Geijtenbeek TB, Van Vliet SJ, Koppel EA et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197:7–17.PubMedCrossRefGoogle Scholar
  52. 52.
    Tailleux L, Schwartz O, Herrmann JL et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003; 197:121–127.PubMedCrossRefGoogle Scholar
  53. 53.
    Simmons G, Reeves JD, Grogan CC et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003; 305:115–123.PubMedCrossRefGoogle Scholar
  54. 54.
    Kaushal GP, Elbein AD. Glycosidase inhibitors in study of glycoconjugates. Methods Enzymol 1994; 230:316–329.PubMedCrossRefGoogle Scholar
  55. 55.
    Lin G, Simmons G, Pohlmann S et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 2003; 77:1337–1346.PubMedCrossRefGoogle Scholar
  56. 56.
    Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 2001; 276:28939–28945.PubMedCrossRefGoogle Scholar
  57. 57.
    Davis CW, Nguyen HY, Hanna SL et al. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol2006; 80:1290–1301.PubMedCrossRefGoogle Scholar
  58. 58.
    Feldmann H, Nichol ST, Klenk HD et al. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 1994; 199:469–473.PubMedCrossRefGoogle Scholar
  59. 59.
    Powlesland AS, Fisch T, Taylor ME et al. A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 2008; 283(1):593–602.PubMedCrossRefGoogle Scholar
  60. 60.
    Alvarez CP, Lasala F, Carrillo J et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002; 76:6841–6844.PubMedCrossRefGoogle Scholar
  61. 61.
    Marzi A, Gramberg T, Simmons G et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004; 78:12090–12095.PubMedCrossRefGoogle Scholar
  62. 62.
    Gramberg T, Hofmann H, Moller P et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005; 340:224–36.PubMedCrossRefGoogle Scholar
  63. 63.
    Soilleux EJ, Morris LS, Leslie G et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002; 71:445–457.PubMedGoogle Scholar
  64. 64.
    Soilleux EJ, Morris LS, Lee B et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol 2001; 195:586–592.PubMedCrossRefGoogle Scholar
  65. 65.
    McCully ML, Chau TA, Luke P et al. Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis. Clin Exp Immunol 2005; 139:513–525.PubMedCrossRefGoogle Scholar
  66. 66.
    Lai WK, Sun PJ, Zhang J et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol 2006; 169:200–208.PubMedCrossRefGoogle Scholar
  67. 67.
    Bashirova AA, Geijtenbeek TB, van Duijnhoven GC et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001; 193:671–678.PubMedCrossRefGoogle Scholar
  68. 68.
    Becker S, Spiess M, Klenk HD. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol 1995; 76:393–399.PubMedCrossRefGoogle Scholar
  69. 69.
    Meier M, Bider MD, Malashkevich VN et al. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J Mol Biol 2000; 300:857–865.PubMedCrossRefGoogle Scholar
  70. 70.
    Takada A, Fujioka K, Tsuiji M et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 2004; 78:2943–2947.PubMedCrossRefGoogle Scholar
  71. 71.
    Sieczkarski SB, Whittaker GR. Dissecting virus entry via endocytosis. J Gen Virol 2002; 83:1535–1545.PubMedGoogle Scholar
  72. 72.
    Empig CJ, Goldsmith MA. Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 2002; 76:5266–5270.PubMedCrossRefGoogle Scholar
  73. 73.
    Bavari S, Bosio CM, Wiegand E et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 2002; 195:593–602.PubMedCrossRefGoogle Scholar
  74. 74.
    Bhattacharyya S, Warfield KL, Ruthel G et al. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 2010; 401:18–28.PubMedCrossRefGoogle Scholar
  75. 75.
    Saeed MF, Kolokoltsov AA, Albrecht T et al. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 2010; 6:e1001110.PubMedCrossRefGoogle Scholar
  76. 76.
    Nanbo A, Imai, M, Watanabe S et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 2010; 6:e1001121.PubMedCrossRefGoogle Scholar
  77. 77.
    Aleksandrowicz P, Marzi A, Biedenkopf N et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis 2011; 204:S957–S967.PubMedCrossRefGoogle Scholar
  78. 78.
    Hunt CL, Kolokoltsov AA, Davey RA et al. The tyro3 receptor kinase axl enhances macropinocytosis of zaire ebolavirus. J Virol 2011; 85:334–347.PubMedCrossRefGoogle Scholar
  79. 79.
    Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001;70:777–810.PubMedCrossRefGoogle Scholar
  80. 80.
    Mothes W, Boerger AL, Narayan S et al. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 2000; 103(4):679–689.PubMedCrossRefGoogle Scholar
  81. 81.
    Bar S, Takada A, Kawaoka Y et al. Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol 2006; 80(6):2815–2822.PubMedCrossRefGoogle Scholar
  82. 82.
    Ito H, Watanabe S, Sanchez A et al. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 1999; 73(10):8907–8912.PubMedGoogle Scholar
  83. 83.
    Simmons G, Reeves JD, Rennekamp AJ et al. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci USA 2004; 101(12):4240–4245.PubMedCrossRefGoogle Scholar
  84. 84.
    Chandran K, Sullivan NJ, Felbor U et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308(5728):1643–1645.PubMedCrossRefGoogle Scholar
  85. 85.
    Schornberg K, Matsuyama S, Kabsch K et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 2006; 80(8):4174–4178.PubMedCrossRefGoogle Scholar
  86. 86.
    Misasi J, Chandran K, Yang JY et al. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol 2012; 86(6):3284–3292.PubMedCrossRefGoogle Scholar
  87. 87.
    Gnirss K, Kühl A, Karsten C et al. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 2012; 424(1):3–10.PubMedCrossRefGoogle Scholar
  88. 88.
    Ebert DH, Deussing J, Peters C et al. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 2002; 277(27):24609–24617.PubMedCrossRefGoogle Scholar
  89. 89.
    Simmons G, Gosalia DN, Rennekamp AJ et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 2005; 102(33):11876–11881.PubMedCrossRefGoogle Scholar
  90. 90.
    Qiu Z, Hingley ST, Simmons G et al. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol 2006; 80(12):5768–5776.PubMedCrossRefGoogle Scholar
  91. 91.
    Carette JE, Raaben M, Wong AC et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011; 477(7364):340–343.PubMedCrossRefGoogle Scholar
  92. 92.
    Cote M, Misasi J, Ren T et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011; 477(7364):344–348.PubMedCrossRefGoogle Scholar
  93. 93.
    Miller EH, Obernosterer G, Raaben M et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 2012; 31(8):1947–1960.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2013

Authors and Affiliations

  • Graham Simmons
    • 1
  1. 1.Blood Systems Research Institute; Department of Laboratory MedicineUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations